Your browser doesn't support javascript.
loading
[Comparison of the efficacy and safety of 2 low-dose rituximab regimens in the second-line treatment of primary immune thrombocytopenia in children].
Zhu, X J; Ma, J Y; Chen, Z P; Xie, X J; Zhang, J L; Ma, J; Yao, J F; Zhang, L Q; Wu, R H.
Afiliación
  • Zhu XJ; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Ma JY; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Chen ZP; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing 100045, China.
  • Xie XJ; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Zhang JL; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Ma J; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Yao JF; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Zhang LQ; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
  • Wu RH; Hematology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing 100045, Chin
Zhonghua Er Ke Za Zhi ; 60(11): 1185-1190, 2022 Nov 02.
Article en Zh | MEDLINE | ID: mdl-36319155
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática Tipo de estudio: Observational_studies Límite: Child / Female / Humans / Male Idioma: Zh Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática Tipo de estudio: Observational_studies Límite: Child / Female / Humans / Male Idioma: Zh Año: 2022 Tipo del documento: Article